The Enterprise Value as of December 2025 (TTM) for Coya Therapeutics, Inc. (COYA) is -29657635354.00

According to Coya Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -29657635354.00. This represents a change of 302.60% compared to the average of -7366500278.13 of the last 4 quarters.

Coya Therapeutics, Inc. (COYA) Historical Enterprise Value (quarterly & annually)

How has COYA Enterprise Value performed in the past?

The mean historical Enterprise Value of Coya Therapeutics, Inc. over the last ten years is 37.28M. The current -29657635354.00 Enterprise Value has changed -7956469.48% with respect to the historical average. Over the past ten years (40 quarters), COYA's Enterprise Value was at its highest in in the March 2024 quarter at 105.70M. The Enterprise Value was at its lowest in in the June 2025 quarter at -29661159261.50.

Coya Therapeutics, Inc. (COYA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Coya Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Coya Therapeutics, Inc. (COYA) Average Enterprise Value

How has COYA Enterprise Value performed in the past?

The current Enterprise Value of Coya Therapeutics, Inc. (COYA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Coya Therapeutics, Inc. (COYA) Enterprise Value vs. Peers

How is COYA’s Enterprise Value compared to its peers?

Coya Therapeutics, Inc.’s Enterprise Value is less than Immix Biopharma, Inc. (147.65M), less than Clene Inc. (72.09M), less than MacroGenics, Inc. (44.18M), less than Oramed Pharmaceuticals Inc. (98.45M), less than Ovid Therapeutics Inc. (96.01M), less than Context Therapeutics Inc. (11.29M), less than Pliant Therapeutics, Inc. (16.18M), less than Whitehawk Therapeutics Inc (-24287393.00), less than Shattuck Labs, Inc. (101.48M), less than Zentalis Pharmaceuticals, Inc. (101.24M),

Build a custom stock screener for Coya Therapeutics, Inc. (COYA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Coya Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Coya Therapeutics, Inc. (COYA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Coya Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.